Is collecting a sample of prelesional skin from a patient suspected of having bullous pemphigoid, storing it in soaked saline gauze, and covering both the gauze and sample with saline solution an appropriate method?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The method of collecting a sample of prelesional skin from a patient suspected of having bullous pemphigoid, storing it in soaked saline gauze, and covering both the gauze and sample with saline solution is not an appropriate method for diagnosis. This approach does not adequately preserve the immunoreactants necessary for accurate diagnosis through direct immunofluorescence (DIF) testing, which is a crucial step in confirming the diagnosis of bullous pemphigoid 1.

Key Considerations for Sample Collection

  • The preferred method involves obtaining a skin biopsy from perilesional skin, within 1-2 cm of an active blister.
  • The biopsy should be divided into two specimens: one for routine histopathology in formalin and the other for DIF testing in Michel's transport medium or frozen in liquid nitrogen.
  • Michel's medium is ideal for preserving immunoreactants for up to 2 weeks at room temperature, making it suitable for transport to reference laboratories 1.
  • If Michel's medium is not available, snap-freezing in liquid nitrogen or placing the specimen on saline-moistened gauze and transporting it immediately on ice are alternatives, though they are less reliable.

Importance of Proper Preservation

  • Proper preservation of tissue architecture and immunoreactants is essential for diagnosing bullous pemphigoid through both histopathology and direct immunofluorescence.
  • A 3-4 mm punch biopsy that includes intact epidermis and sufficient dermis is typically required for optimal results.
  • The diagnosis of bullous pemphigoid is based on a combination of clinical features, compatible light microscopy findings, and positive direct immunofluorescence microscopy (DIF) findings, as outlined in recent guidelines 1.

Clinical Implications

  • Accurate diagnosis is critical for initiating appropriate treatment and improving patient outcomes in terms of morbidity, mortality, and quality of life.
  • The method of sample collection and preservation is a critical step in the diagnostic process for bullous pemphigoid, and using the most effective and reliable methods is essential for ensuring accurate diagnoses and optimal patient care 1.

From the Research

Sample Collection and Storage

  • Collecting a sample of prelesional skin from a patient suspected of having bullous pemphigoid is a crucial step in diagnosis 2.
  • However, the provided studies do not specifically address the method of storing the sample in soaked saline gauze and covering it with saline solution.
  • A study from 1995 discusses the use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases, including bullous pemphigoid 3.
  • This study highlights the importance of proper sample handling and storage for accurate diagnosis, but it does not provide information on the specific method mentioned in the question.

Diagnostic Methods

  • Direct immunofluorescence (DIF) of perilesional skin is a key diagnostic tool for bullous pemphigoid, highlighting C3 with or without IgG in a linear pattern along the basement membrane 2.
  • A 10-year study on discordant results on direct immunofluorescence in bullous pemphigoid found that repeat biopsies may be required for a definitive DIF diagnosis, as initial DIF evaluation may result in a false-negative result 2.
  • Other studies discuss the importance of clinical, histopathologic, and immunopathologic examination in diagnosing bullous pemphigoid 4, 5, 6.

Treatment and Management

  • The management of bullous pemphigoid depends on the severity of the disease and the patient's comorbidities 4.
  • High-potency topical corticosteroids are recommended as the mainstay of treatment, with oral prednisone as an alternative 4.
  • Other treatment options, such as immunosuppressive therapies and B-cell-depleting therapy, may be considered in certain cases 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.